The Diabetes and Hormone Action Training program at the University of Virginia promotes the academic development of basic and clinical scientists who will focus their research efforts in the area of diabetes and related disorders. It is a centerpiece of our expansive Diabetes Center research program. Diabetes itself is a complex a disorders including multiple varieties of type 1 and type 2 diabetes, and there are multiple syndromes allied to diabetes (e.g. "pre-diabetes", the insulin resistance syndrome, polycystic ovarian disease, etc.). Trainees must be equipped with a broad understanding of the diverse pathogenetic mechanisms involved in the development of both diabetes and its complications. The environment of the University of Virginia's Diabetes Center is well-suited as a focal center for training program in diabetes and hormone action. The Center is interdepartmental, reporting directly to the Dean of the School of Medicine. It is home to the UVA DERC and contains considerable research resources in the form of laboratory space, well-equipped core laboratories, and a complement of over 50junior and senior investigators involved in either clinical or basic research related to diabetes. The training programs major strength is this outstanding group of program faculty with established national and international reputations in the area of diabetes, hormone action, cell signaling, islet cell function, and clinical investigation. The Center runs its ownweekly research in progress seminar program. This is an intellectual focal point and affords trainees the opportunity to interact with many UVA faculty as well as with distinguished scientists from many institutions. It also provides an excellent opportunity for trainees to present their own research projects. Most importantly, the Center is a highly interactive community of scientists who collaborate on projects that impact on many areas of diabetes, hormone action, and cellular signaling. The training program has been in operation for 29 years. During that time over 95 fellows have been trained. Acceptance into the program is decided by the Training Grant Executive Committee. Over the entire duration of the program approximately 48 percent of trainees are M.D.s and 52 percent Ph.D. graduates. Most currently hold positions as investigators at academic institutions or in the biomedical research industry throughout the United States. Training focuses on specific projects in laboratory of the mentoring investigators and is individualized to specific needs and careergoals of the trainee. The training occurs in an interdisciplinary atmosphere, often involving collaborative input from both clinical and basic scientists. The atmosphere of interdepartmental and interdisciplinary cooperation with a focus on a complex disease such as diabetes is well-suited to training bright, creative future investigators.

National Institute of Health (NIH)
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Institutional National Research Service Award (T32)
Project #
Application #
Study Section
Diabetes, Endocrinology and Metabolic Diseases B Subcommittee (DDK)
Program Officer
Castle, Arthur
Project Start
Project End
Budget Start
Budget End
Support Year
Fiscal Year
Total Cost
Indirect Cost
University of Virginia
Internal Medicine/Medicine
Schools of Medicine
United States
Zip Code
Subaran, Sharmila C; Sauder, Matthew A; Chai, Weidong et al. (2014) GLP-1 at physiological concentrations recruits skeletal and cardiac muscle microvasculature in healthy humans. Clin Sci (Lond) 127:163-70
Upchurch, Charles T; Barrett, Eugene J (2012) Clinical review: Screening for coronary artery disease in type 2 diabetes. J Clin Endocrinol Metab 97:1434-42
Majumdar, S; Genders, A J; Inyard, A C et al. (2012) Insulin entry into muscle involves a saturable process in the vascular endothelium. Diabetologia 55:450-6
Kashmer, Laurissa; Clarke, William; Gurka, Matthew et al. (2009) Predictors of parental interest in continuous glucose monitoring for children with type 1 diabetes. Diabetes Technol Ther 11:373-8
Davies, Lucinda A; Hu, Changlong; Guagliardo, Nick A et al. (2008) TASK channel deletion in mice causes primary hyperaldosteronism. Proc Natl Acad Sci U S A 105:2203-8
McDuffie, Marcia; Maybee, Nelly A; Keller, Susanna R et al. (2008) Nonobese diabetic (NOD) mice congenic for a targeted deletion of 12/15-lipoxygenase are protected from autoimmune diabetes. Diabetes 57:199-208
Wang, Hong; Liu, Zhenqi; Li, Guolian et al. (2006) The vascular endothelial cell mediates insulin transport into skeletal muscle. Am J Physiol Endocrinol Metab 291:E323-32
Francis, Joshua; Babu, Daniella A; Deering, Tye G et al. (2006) Role of chromatin accessibility in the occupancy and transcription of the insulin gene by the pancreatic and duodenal homeobox factor 1. Mol Endocrinol 20:3133-45
Iype, Tessy; Taylor, David G; Ziesmann, Suzanne M et al. (2004) The transcriptional repressor Nkx6.1 also functions as a deoxyribonucleic acid context-dependent transcriptional activator during pancreatic beta-cell differentiation: evidence for feedback activation of the nkx6.1 gene by Nkx6.1. Mol Endocrinol 18:1363-75
Chrestensen, Carol A; Schroeder, Melanie J; Shabanowitz, Jeffrey et al. (2004) MAPKAP kinase 2 phosphorylates tristetraprolin on in vivo sites including Ser178, a site required for 14-3-3 binding. J Biol Chem 279:10176-84

Showing the most recent 10 out of 47 publications